Western-style  ||| S:0 E:14 ||| JJ
diet ||| S:14 E:18 ||| NN
,  ||| S:18 E:20 ||| ,
with  ||| S:20 E:25 ||| IN
and  ||| S:25 E:29 ||| CC
without  ||| S:29 E:37 ||| IN
chronic  ||| S:37 E:45 ||| JJ
androgen  ||| S:45 E:54 ||| JJ
treatment ||| S:54 E:63 ||| NN
,  ||| S:63 E:65 ||| ,
alters  ||| S:65 E:72 ||| VBG
the  ||| S:72 E:76 ||| DT
number ||| S:76 E:82 ||| NN
,  ||| S:82 E:84 ||| ,
structure ||| S:84 E:93 ||| NN
,  ||| S:93 E:95 ||| ,
and  ||| S:95 E:99 ||| CC
function  ||| S:99 E:108 ||| NN
of  ||| S:108 E:111 ||| IN
small  ||| S:111 E:117 ||| JJ
antral  ||| S:117 E:124 ||| JJ
follicles  ||| S:124 E:134 ||| NN
in  ||| S:134 E:137 ||| IN
ovaries  ||| S:137 E:145 ||| NN
of  ||| S:145 E:148 ||| IN
young  ||| S:148 E:154 ||| JJ
adult  ||| S:154 E:160 ||| NN
monkeys  ||| S:160 E:168 ||| NNS
To  ||| S:168 E:171 ||| TO
examine  ||| S:171 E:179 ||| VB
the  ||| S:179 E:183 ||| DT
small  ||| S:183 E:189 ||| JJ
antral  ||| S:189 E:196 ||| JJ
follicle  ||| S:196 E:205 ||| NNS
( ||| S:205 E:206 ||| -LRB-
SAF ||| S:206 E:209 ||| NNP
)  ||| S:209 E:211 ||| -RRB-
cohort  ||| S:211 E:218 ||| NN
in  ||| S:218 E:221 ||| IN
ovaries  ||| S:221 E:229 ||| NN
of  ||| S:229 E:232 ||| IN
adult  ||| S:232 E:238 ||| NN
rhesus  ||| S:238 E:245 ||| NN
monkeys  ||| S:245 E:253 ||| NNS
after  ||| S:253 E:259 ||| IN
consumption  ||| S:259 E:271 ||| NN
of  ||| S:271 E:274 ||| IN
a  ||| S:274 E:276 ||| DT
Western-style  ||| S:276 E:290 ||| JJ
diet  ||| S:290 E:295 ||| NN
( ||| S:295 E:296 ||| -LRB-
WSD ||| S:296 E:299 ||| NNP
) ||| S:299 E:300 ||| -RRB-
,  ||| S:300 E:302 ||| ,
with  ||| S:302 E:307 ||| IN
or  ||| S:307 E:310 ||| CC
without  ||| S:310 E:318 ||| IN
chronically  ||| S:318 E:330 ||| RB
elevated  ||| S:330 E:339 ||| VBD
androgen  ||| S:339 E:348 ||| JJ
levels  ||| S:348 E:355 ||| NNS
since  ||| S:355 E:361 ||| IN
before  ||| S:361 E:368 ||| IN
puberty ||| S:368 E:375 ||| NN
.  ||| S:375 E:377 ||| .
Cholesterol  ||| S:377 E:389 ||| NN
or  ||| S:389 E:392 ||| CC
T  ||| S:392 E:394 ||| NN
( ||| S:394 E:395 ||| -LRB-
n  ||| S:395 E:397 ||| CD
=  ||| S:397 E:399 ||| SYM
6  ||| S:399 E:401 ||| CD
per  ||| S:401 E:405 ||| IN
group ||| S:405 E:410 ||| NN
)  ||| S:410 E:412 ||| -RRB-
implants  ||| S:412 E:421 ||| NN
were  ||| S:421 E:426 ||| VBD
placed  ||| S:426 E:433 ||| VBN
SC  ||| S:433 E:436 ||| NNP
in  ||| S:436 E:439 ||| IN
female  ||| S:439 E:446 ||| JJ
rhesus  ||| S:446 E:453 ||| NNS
macaques  ||| S:453 E:462 ||| VBP
beginning  ||| S:462 E:472 ||| VBG
at  ||| S:472 E:475 ||| IN
1 year  ||| S:475 E:482 ||| CD
of  ||| S:482 E:485 ||| IN
age  ||| S:485 E:489 ||| NN
( ||| S:489 E:490 ||| -LRB-
prepubertal ||| S:490 E:501 ||| LS
) ||| S:501 E:502 ||| -RRB-
,  ||| S:502 E:504 ||| ,
with  ||| S:504 E:509 ||| IN
addition  ||| S:509 E:518 ||| NN
of  ||| S:518 E:521 ||| IN
a  ||| S:521 E:523 ||| DT
WSD  ||| S:523 E:527 ||| NNP
( ||| S:527 E:528 ||| -LRB-
high  ||| S:528 E:533 ||| JJ
fat ||| S:533 E:536 ||| JJ
/ ||| S:536 E:537 ||| CD
fructose ||| S:537 E:545 ||| CD
)  ||| S:545 E:547 ||| -RRB-
at  ||| S:547 E:550 ||| IN
5.5 years  ||| S:550 E:560 ||| NNP
( ||| S:560 E:561 ||| -LRB-
menarche  ||| S:561 E:570 ||| FW
approximately  ||| S:570 E:584 ||| FW
2.6 years ||| S:584 E:593 ||| FW
) ||| S:593 E:594 ||| -RRB-
.  ||| S:594 E:596 ||| .
Ovaries  ||| S:596 E:604 ||| NNP
were  ||| S:604 E:609 ||| VBD
collected  ||| S:609 E:619 ||| VBN
at  ||| S:619 E:622 ||| IN
7 years  ||| S:622 E:630 ||| CD
of  ||| S:630 E:633 ||| IN
age ||| S:633 E:636 ||| NN
.  ||| S:636 E:638 ||| .
One  ||| S:638 E:642 ||| CD
ovary  ||| S:642 E:648 ||| NN
per  ||| S:648 E:652 ||| IN
female  ||| S:652 E:659 ||| NN
was  ||| S:659 E:663 ||| VBD
embedded  ||| S:663 E:672 ||| VBN
in  ||| S:672 E:675 ||| IN
paraffin  ||| S:675 E:684 ||| NN
for  ||| S:684 E:688 ||| IN
morphologic  ||| S:688 E:700 ||| NN
and  ||| S:700 E:704 ||| CC
immunohistochemical  ||| S:704 E:724 ||| JJ
analyses ||| S:724 E:732 ||| NNS
.  ||| S:732 E:734 ||| .
The  ||| S:734 E:738 ||| DT
SAFs  ||| S:738 E:743 ||| JJ
(  ||| S:743 E:744 ||| -LRB-
< ||| S:744 E:745 ||| SYM
2.5 mm ||| S:745 E:751 ||| NNP
)  ||| S:751 E:753 ||| -RRB-
were  ||| S:753 E:758 ||| VBD
dissected  ||| S:758 E:768 ||| VBN
from  ||| S:768 E:773 ||| IN
the  ||| S:773 E:777 ||| DT
other  ||| S:777 E:783 ||| JJ
ovary  ||| S:783 E:789 ||| NNS
obtained  ||| S:789 E:798 ||| VBN
at  ||| S:798 E:801 ||| IN
or  ||| S:801 E:804 ||| CC
near  ||| S:804 E:809 ||| JJ
menses  ||| S:809 E:816 ||| NN
in  ||| S:816 E:819 ||| IN
a  ||| S:819 E:821 ||| DT
subgroup  ||| S:821 E:830 ||| NN
of  ||| S:830 E:833 ||| IN
females  ||| S:833 E:841 ||| NNS
( ||| S:841 E:842 ||| -LRB-
n  ||| S:842 E:844 ||| CD
=  ||| S:844 E:846 ||| SYM
3  ||| S:846 E:848 ||| CD
per  ||| S:848 E:852 ||| IN
group ||| S:852 E:857 ||| NN
)  ||| S:857 E:859 ||| -RRB-
and  ||| S:859 E:863 ||| CC
processed  ||| S:863 E:873 ||| VBN
for  ||| S:873 E:877 ||| IN
microarray  ||| S:877 E:888 ||| JJ
analyses  ||| S:888 E:897 ||| NNS
of  ||| S:897 E:900 ||| IN
the  ||| S:900 E:904 ||| DT
SAF  ||| S:904 E:908 ||| NNP
transcriptome ||| S:908 E:921 ||| NN
.  ||| S:921 E:923 ||| .
Ovaries  ||| S:923 E:931 ||| NNP
of  ||| S:931 E:934 ||| IN
adult  ||| S:934 E:940 ||| NN
monkeys  ||| S:940 E:948 ||| NNS
consuming  ||| S:948 E:958 ||| VBP
a  ||| S:958 E:960 ||| DT
standard  ||| S:960 E:969 ||| JJ
macaque  ||| S:969 E:977 ||| JJ
diet  ||| S:977 E:982 ||| NN
( ||| S:982 E:983 ||| -LRB-
low  ||| S:983 E:987 ||| JJ
in  ||| S:987 E:990 ||| IN
fats  ||| S:990 E:995 ||| NNS
and  ||| S:995 E:999 ||| CC
sugars ||| S:999 E:1005 ||| CD
)  ||| S:1005 E:1007 ||| -RRB-
were  ||| S:1007 E:1012 ||| VBD
obtained  ||| S:1012 E:1021 ||| VBN
at  ||| S:1021 E:1024 ||| IN
similar  ||| S:1024 E:1032 ||| JJ
stages  ||| S:1032 E:1039 ||| NNS
of  ||| S:1039 E:1042 ||| IN
the  ||| S:1042 E:1046 ||| DT
menstrual  ||| S:1046 E:1056 ||| JJ
cycle  ||| S:1056 E:1062 ||| NN
and  ||| S:1062 E:1066 ||| CC
used  ||| S:1066 E:1071 ||| VBN
as  ||| S:1071 E:1074 ||| IN
controls  ||| S:1074 E:1083 ||| NNS
for  ||| S:1083 E:1087 ||| IN
all  ||| S:1087 E:1091 ||| DT
analyses ||| S:1091 E:1099 ||| NNS
.  ||| S:1099 E:1101 ||| .
Primate  ||| S:1101 E:1109 ||| JJ
research  ||| S:1109 E:1118 ||| NN
center ||| S:1118 E:1124 ||| NN
.  ||| S:1124 E:1126 ||| .
Adult ||| S:1126 E:1131 ||| NNP
,  ||| S:1131 E:1133 ||| ,
female  ||| S:1133 E:1140 ||| JJ
rhesus  ||| S:1140 E:1147 ||| JJ
monkeys  ||| S:1147 E:1155 ||| NNS
( ||| S:1155 E:1156 ||| -LRB-
Macaca  ||| S:1156 E:1163 ||| UH
mulatta ||| S:1163 E:1170 ||| UH
) ||| S:1170 E:1171 ||| -RRB-
.  ||| S:1171 E:1173 ||| .
None ||| S:1173 E:1177 ||| NN
.  ||| S:1177 E:1179 ||| .
Histologic  ||| S:1179 E:1190 ||| JJ
analyses ||| S:1190 E:1198 ||| NNS
,  ||| S:1198 E:1200 ||| ,
SAF  ||| S:1200 E:1204 ||| NNP
counts  ||| S:1204 E:1211 ||| NNS
and  ||| S:1211 E:1215 ||| CC
morphology ||| S:1215 E:1225 ||| NN
,  ||| S:1225 E:1227 ||| ,
protein  ||| S:1227 E:1235 ||| NN
localization  ||| S:1235 E:1248 ||| NNS
and  ||| S:1248 E:1252 ||| CC
abundance  ||| S:1252 E:1262 ||| NN
in  ||| S:1262 E:1265 ||| IN
SAFs ||| S:1265 E:1269 ||| NNP
,  ||| S:1269 E:1271 ||| ,
transcriptome  ||| S:1271 E:1285 ||| VBG
in  ||| S:1285 E:1288 ||| IN
SAFs  ||| S:1288 E:1293 ||| NNP
( ||| S:1293 E:1294 ||| -LRB-
messenger  ||| S:1294 E:1304 ||| FW
RNAs  ||| S:1304 E:1309 ||| FW
[ ||| S:1309 E:1310 ||| -LRB-
mRNAs ||| S:1310 E:1315 ||| NNP
] ||| S:1315 E:1316 ||| -RRB-
) ||| S:1316 E:1317 ||| -RRB-
.  ||| S:1317 E:1319 ||| .
Compared  ||| S:1319 E:1328 ||| VBN
with  ||| S:1328 E:1333 ||| IN
controls ||| S:1333 E:1341 ||| NNS
,  ||| S:1341 E:1343 ||| ,
consumption  ||| S:1343 E:1355 ||| NN
of  ||| S:1355 E:1358 ||| IN
a  ||| S:1358 E:1360 ||| DT
WSD ||| S:1360 E:1363 ||| NNP
,  ||| S:1363 E:1365 ||| ,
with  ||| S:1365 E:1370 ||| IN
and  ||| S:1370 E:1374 ||| CC
without  ||| S:1374 E:1382 ||| IN
T  ||| S:1382 E:1384 ||| NN
treatment ||| S:1384 E:1393 ||| NN
,  ||| S:1393 E:1395 ||| ,
increased  ||| S:1395 E:1405 ||| VBD
the  ||| S:1405 E:1409 ||| DT
numbers  ||| S:1409 E:1417 ||| NNS
of  ||| S:1417 E:1420 ||| IN
SAFs  ||| S:1420 E:1425 ||| JJ
per  ||| S:1425 E:1429 ||| IN
ovary ||| S:1429 E:1434 ||| NN
,  ||| S:1434 E:1436 ||| ,
owing  ||| S:1436 E:1442 ||| VBG
to  ||| S:1442 E:1445 ||| TO
the  ||| S:1445 E:1449 ||| DT
presence  ||| S:1449 E:1458 ||| NN
of  ||| S:1458 E:1461 ||| IN
more  ||| S:1461 E:1466 ||| RBR
atretic  ||| S:1466 E:1474 ||| JJ
follicles ||| S:1474 E:1483 ||| NN
.  ||| S:1483 E:1485 ||| .
Numbers  ||| S:1485 E:1493 ||| NNS
of  ||| S:1493 E:1496 ||| IN
granulosa  ||| S:1496 E:1506 ||| JJ
cells  ||| S:1506 E:1512 ||| NNS
expressing  ||| S:1512 E:1523 ||| VBG
cellular  ||| S:1523 E:1532 ||| JJ
proliferation  ||| S:1532 E:1546 ||| NN
markers  ||| S:1546 E:1554 ||| NNS
( ||| S:1554 E:1555 ||| -LRB-
pRb  ||| S:1555 E:1559 ||| NNP
and  ||| S:1559 E:1563 ||| CC
pH3 ||| S:1563 E:1566 ||| CD
)  ||| S:1566 E:1568 ||| -RRB-
was  ||| S:1568 E:1572 ||| VBD
greater  ||| S:1572 E:1580 ||| JJR
in  ||| S:1580 E:1583 ||| IN
healthy  ||| S:1583 E:1591 ||| JJ
SAFs ||| S:1591 E:1595 ||| NN
,  ||| S:1595 E:1597 ||| ,
whereas  ||| S:1597 E:1605 ||| IN
numbers  ||| S:1605 E:1613 ||| NNS
of  ||| S:1613 E:1616 ||| IN
cells  ||| S:1616 E:1622 ||| NNS
expressing  ||| S:1622 E:1633 ||| VBG
the  ||| S:1633 E:1637 ||| DT
cell  ||| S:1637 E:1642 ||| NN
cycle  ||| S:1642 E:1648 ||| NN
inhibitor  ||| S:1648 E:1658 ||| NNS
( ||| S:1658 E:1659 ||| -LRB-
p21 ||| S:1659 E:1662 ||| NNP
)  ||| S:1662 E:1664 ||| -RRB-
was  ||| S:1664 E:1668 ||| VBD
higher  ||| S:1668 E:1675 ||| JJR
in  ||| S:1675 E:1678 ||| IN
atretic  ||| S:1678 E:1686 ||| JJ
SAFs ||| S:1686 E:1690 ||| NN
.  ||| S:1690 E:1692 ||| .
Intense  ||| S:1692 E:1700 ||| JJ
CYP17A1  ||| S:1700 E:1708 ||| CD
staining  ||| S:1708 E:1717 ||| NNS
was  ||| S:1717 E:1721 ||| VBD
observed  ||| S:1721 E:1730 ||| VBN
in  ||| S:1730 E:1733 ||| IN
the  ||| S:1733 E:1737 ||| DT
theca  ||| S:1737 E:1743 ||| JJ
cells  ||| S:1743 E:1749 ||| NNS
of  ||| S:1749 E:1752 ||| IN
SAFs  ||| S:1752 E:1757 ||| JJ
from  ||| S:1757 E:1762 ||| IN
WSD  ||| S:1762 E:1766 ||| NNP
with  ||| S:1766 E:1771 ||| IN
or  ||| S:1771 E:1774 ||| CC
without  ||| S:1774 E:1782 ||| IN
T  ||| S:1782 E:1784 ||| NN
groups ||| S:1784 E:1790 ||| NNS
,  ||| S:1790 E:1792 ||| ,
compared  ||| S:1792 E:1801 ||| VBN
with  ||| S:1801 E:1806 ||| IN
controls ||| S:1806 E:1814 ||| NNS
.  ||| S:1814 E:1816 ||| .
Microarray  ||| S:1816 E:1827 ||| JJ
analyses  ||| S:1827 E:1836 ||| NNS
of  ||| S:1836 E:1839 ||| IN
the  ||| S:1839 E:1843 ||| DT
transcriptome  ||| S:1843 E:1857 ||| NN
in  ||| S:1857 E:1860 ||| IN
SAFs  ||| S:1860 E:1865 ||| JJ
isolated  ||| S:1865 E:1874 ||| NN
from  ||| S:1874 E:1879 ||| IN
WSD  ||| S:1879 E:1883 ||| NNP
and  ||| S:1883 E:1887 ||| CC
WSD  ||| S:1887 E:1891 ||| NNP
plus  ||| S:1891 E:1896 ||| CC
T-treated  ||| S:1896 E:1906 ||| JJ
females  ||| S:1906 E:1914 ||| NNS
and  ||| S:1914 E:1918 ||| CC
controls  ||| S:1918 E:1927 ||| NNS
consuming  ||| S:1927 E:1937 ||| VBP
a  ||| S:1937 E:1939 ||| DT
standard  ||| S:1939 E:1948 ||| JJ
diet  ||| S:1948 E:1953 ||| NN
identified  ||| S:1953 E:1964 ||| VBD
1,944  ||| S:1964 E:1970 ||| CD
genes  ||| S:1970 E:1976 ||| NNS
whose  ||| S:1976 E:1982 ||| WP$
mRNA  ||| S:1982 E:1987 ||| JJ
levels  ||| S:1987 E:1994 ||| NNS
changed  ||| S:1994 E:2002 ||| VBD
twofold  ||| S:2002 E:2010 ||| JJ
or  ||| S:2010 E:2013 ||| CC
more  ||| S:2013 E:2018 ||| JJR
among  ||| S:2018 E:2024 ||| IN
the  ||| S:2024 E:2028 ||| DT
three  ||| S:2028 E:2034 ||| CD
groups ||| S:2034 E:2040 ||| NNS
.  ||| S:2040 E:2042 ||| .
Further  ||| S:2042 E:2050 ||| JJ
analyses  ||| S:2050 E:2059 ||| NNS
identified  ||| S:2059 E:2070 ||| VBN
several  ||| S:2070 E:2078 ||| JJ
gene  ||| S:2078 E:2083 ||| NN
pathways  ||| S:2083 E:2092 ||| VBZ
altered  ||| S:2092 E:2100 ||| VBN
by  ||| S:2100 E:2103 ||| IN
WSD  ||| S:2103 E:2107 ||| NNP
and ||| S:2107 E:2110 ||| CC
/ ||| S:2110 E:2111 ||| NNP
or  ||| S:2111 E:2114 ||| CC
WSD  ||| S:2114 E:2118 ||| NNP
plus  ||| S:2118 E:2123 ||| CC
T  ||| S:2123 E:2125 ||| NN
associated  ||| S:2125 E:2136 ||| VBN
with  ||| S:2136 E:2141 ||| IN
steroid ||| S:2141 E:2148 ||| NN
,  ||| S:2148 E:2150 ||| ,
carbohydrate ||| S:2150 E:2162 ||| NN
,  ||| S:2162 E:2164 ||| ,
and  ||| S:2164 E:2168 ||| CC
lipid  ||| S:2168 E:2174 ||| JJ
metabolism ||| S:2174 E:2184 ||| NN
,  ||| S:2184 E:2186 ||| ,
plus  ||| S:2186 E:2191 ||| CC
ovarian  ||| S:2191 E:2199 ||| JJ
processes ||| S:2199 E:2208 ||| NNS
.  ||| S:2208 E:2210 ||| .
Alterations  ||| S:2210 E:2222 ||| NNP
in  ||| S:2222 E:2225 ||| IN
levels  ||| S:2225 E:2232 ||| NNS
of  ||| S:2232 E:2235 ||| IN
several  ||| S:2235 E:2243 ||| JJ
SAF  ||| S:2243 E:2247 ||| NNP
mRNAs  ||| S:2247 E:2253 ||| NNP
are  ||| S:2253 E:2257 ||| VBP
similar  ||| S:2257 E:2265 ||| JJ
to  ||| S:2265 E:2268 ||| TO
those  ||| S:2268 E:2274 ||| DT
observed  ||| S:2274 E:2283 ||| NN
in  ||| S:2283 E:2286 ||| IN
follicular  ||| S:2286 E:2297 ||| JJ
cells  ||| S:2297 E:2303 ||| NNS
from  ||| S:2303 E:2308 ||| IN
women  ||| S:2308 E:2314 ||| NNS
with  ||| S:2314 E:2319 ||| IN
polycystic  ||| S:2319 E:2330 ||| JJ
ovary  ||| S:2330 E:2336 ||| JJ
syndrome ||| S:2336 E:2344 ||| NN
.  ||| S:2344 E:2346 ||| .
These  ||| S:2346 E:2352 ||| DT
data  ||| S:2352 E:2357 ||| NNS
indicate  ||| S:2357 E:2366 ||| VBP
that  ||| S:2366 E:2371 ||| DT
consumption  ||| S:2371 E:2383 ||| NN
of  ||| S:2383 E:2386 ||| IN
a  ||| S:2386 E:2388 ||| DT
WSD  ||| S:2388 E:2392 ||| NNP
high  ||| S:2392 E:2397 ||| JJ
in  ||| S:2397 E:2400 ||| IN
fats  ||| S:2400 E:2405 ||| NNS
and  ||| S:2405 E:2409 ||| CC
sugars  ||| S:2409 E:2416 ||| NN
in  ||| S:2416 E:2419 ||| IN
the  ||| S:2419 E:2423 ||| DT
presence  ||| S:2423 E:2432 ||| NN
and  ||| S:2432 E:2436 ||| CC
absence  ||| S:2436 E:2444 ||| NN
of  ||| S:2444 E:2447 ||| IN
chronically  ||| S:2447 E:2459 ||| RB
elevated  ||| S:2459 E:2468 ||| JJ
T  ||| S:2468 E:2470 ||| NN
alters  ||| S:2470 E:2477 ||| VBD
the  ||| S:2477 E:2481 ||| DT
structure  ||| S:2481 E:2491 ||| NN
and  ||| S:2491 E:2495 ||| CC
function  ||| S:2495 E:2504 ||| NN
of  ||| S:2504 E:2507 ||| IN
SAFs  ||| S:2507 E:2512 ||| JJ
within  ||| S:2512 E:2519 ||| IN
primate  ||| S:2519 E:2527 ||| JJ
ovaries ||| S:2527 E:2534 ||| NN
.  ||| S:2534 E:2536 ||| .
